Category Archives: Healthcare

H.C. Wainwright Thinks AzurRx BioPharma Inc’s Stock is Going to Recover

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on AzurRx BioPharma Inc (NASDAQ: AZRX), with a price target of $6. The company’s shares closed yesterday at $2.34, close to its 52-week low of $2.20.

The CMO of Xencor Inc is Exercising Options

Today it was reported that the CMO of Xencor Inc (NASDAQ: XNCR), Paul A. Foster, exercised options to sell 36,341 XNCR shares at $11.05 a share, for a total transaction value of $1.49M. In addition to Paul A. Foster, 3

Roth Capital Reiterates Their Buy Rating on BioDelivery (BDSI)

In a report issued on August 13, Scott Henry from Roth Capital reiterated a Buy rating on BioDelivery (NASDAQ: BDSI), with a price target of $4.50. The company’s shares opened today at $2.65. According to TipRanks.com, Henry is a 4-star

SunTrust Robinson Reiterates Their Buy Rating on Merck & Company (MRK)

SunTrust Robinson analyst John Boris reiterated a Buy rating on Merck & Company (NYSE: MRK) on August 14 and set a price target of $77. The company’s shares opened today at $67.60, close to its 52-week high of $69. According

Cowen & Co. Maintains Their Hold Rating on Regeneron (REGN)

Cowen & Co. analyst Phil Nadeau maintained a Hold rating on Regeneron (NASDAQ: REGN) today and set a price target of $385. The company’s shares opened today at $364.48. According to TipRanks.com, Nadeau is a 5-star analyst with an average

TD Securities Thinks Cipher Pharma’s Stock is Going to Recover

In a new note to investors on August 13, an analyst has provided a rating update for the Healthcare company, Cipher Pharma (TSX: CPH). Lennox Gibbs, an analyst with TD Securities, has upgraded their rating on CPH to Buy on